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Abstract 
RIBOSOMAL SYNTHESIS OF N-METHYLATED PEPTIDES 
Sara Ahadi, MSc. 
A thesis submitted in partial fulfillment of the requirements for the degree of master’s of science at 
Virginia Commonwealth University. 
Virginia Commonwealth University, 2010 
Major Director:          Matthew C T Hartman, Ph.D., Department of Chemistry 
Natural peptide products isolated from various organisms often contain N-methylated backbones. 
Such a modification of backbone of the peptide changes its conformational rigidity. This 
modification improves the biological properties of the peptide, such as improved target affinity, 
proteolytic stability or membrane permeability.  Therefore synthesis of N-methylated peptide 
libraries is valuable in screening for drug-like peptides suitable for therapeutic uses.  
Protein synthesis using recombinant elements (PURE) and Flexizyme were used in order to 
reassign specific codons to N-methyl amino acids. mRNA-dependent translation system enable us 
to make our desired peptides with N-methyl amino acids. This technology is a convenient tool for 
the construction of N-methyl peptide libraries.  
Using Flexizyme in order to make library of N-methyl peptides requires significant amount of 
tRNA. Therefore developing a simple and rapid method for purification of specific tRNA from 
fully modified E. coli total tRNA would be advantageous 
  
x 
Here we reported a new technique in purification of individual tRNAs using fluorous affinity tag. 
From total tRNA, desired tRNA could be charged with related amino acid and tagged with 
fluorous molecule through reductive amination. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 1 
Introduction 
1.1 N-methylated Peptides 
Studies on peptide natural products show that many contain N-methyl amino acids
1
. This N-
methylated backbone brings natural peptides special biological properties such as improved 
target affinity, proteolytic stability or membrane permeability
2
. This modification also alters 
peptides’ conformational rigidity and hydrophobicity
3
.  
 
Figure 1. Cyclosporin 
1.2 peptide library 
A peptide library is a systematic combination of different peptides in large number. It is a 
powerful tool for drug discovery and structural studies. Therefore library of N-methylated 
peptides will be useful in discovery of therapeutic peptides. 
There are many techniques available to generate diverse peptide libraries. Ribosome display is 
one of the recent techniques which is an in vitro selection based on the display of nascent peptide 
2 
 
chain on the surface of the ribosome
4, 5
. Libraries as big as 10
12
 can be made by this technique. 
However selections must be performed under conditions that preserve the integrity of the 
ribosome-mRNA-peptide complex. A more powerful in vitro selection technique is mRNA 
display, in which an mRNA would become directly attached to the peptide through a stable 
covalent link.  mRNA display provides advantages over other techniques because of the potential 
for incorporation of unnatural amino acids as well as the ability to prepare libraries with up to 
10
13 
unique peptides 
6, 7
. 
1.3 In vitro Synthesis of N-methylated peptides 
N-methyl amino acids are valuable components in preparation of N-methylated peptides, which 
have drug-like properties. The backbone N-methylation of these peptides are mostly executed by 
enzymes in multienzyme clusters, called nonribosomal peptide synthetases (NRPSs)
8, 9
. This 
peptide synthesis machinery is template–independent. Their complexity makes it difficult to 
generate desired peptide libraries
10, 11
. On the other hand, the translation machinery expresses 
peptides in an mRNA template-dependent manner, yet only incorporates 20 natural amino acids 
into peptide chain
10
. However manipulations of the translation apparatus enable us to incorporate 
unnatural amino acids into peptides
12
. The main technology for incorporation of unnatural amino 
acids is the PURE system
13
, a reconstituted, in vitro translation consisting of purified 
recombinant factors from Escherichia coli. This system is highly suitable for translation of 
unnatural peptides because it provides the ability to control which amino acid and amino acid 
synthetases can be added to translation mix. This makes it possible to reassign multiple codons to 
N-methyl amino acids by withdrawing the corresponding natural amino acids and synthetases. 
Moreover this method allows us to simultaneously incorporate multiple unnatural amino acids. 
3 
 
Different techniques were used for incorporation of N-methyl amino acids into peptides. One of 
the most common one is amber suppression, in which an orthogonal tRNA, specific for amber 
stop is chemoenzymatically aminoacylated and add to cell free translation system
11-14
. A 
disadvantage of this technique is the inability to simultaneously incorporate two unnatural amino 
acids into a peptide.  
1.4 Flexizyme 
An alternative method in making non-natural aminoacyl tRNAs designed by Suga and 
coworkers, is Flexizyme
14, 15
. Flexizyme is de novo tRNA acylation system. It can be used for the 
preparation of acyl tRNAs with nearly unlimited selection of amino acids and tRNAs
16
. It works 
by recognizing CCA sequence at the 3` of tRNA as well as the aromatic side chain on amino 
acids (Figure 2).  
  
Figure 2. Flexizyme  
If the amino acid has the aromatic group in its side chain, it needs to be activated by a 
cyanomethyl ester (CME) group. Since many amino acids lack aromatic side chains, Suga and 
coworkers developed a Flexizyme variant that recognizes dinitro benzyl esters (DBE) of non-
aromatic amino acids
16
. This mutant Flexizyme is called dinitro-Flexizyme (dFx) has five times 
4 
 
better activity for dinitrobenzyl ester amino acids. The Flexizyme which recognizes aromatic 
amino acids is called enhanced Flexizyme (eFx). 
The combination of the Flexizyme system with PURE translation apparatus allows us to perform 
mRNA-dependent synthesis for preparation of peptides with multiple unnatural amino acids.  
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Chapter 2 
Flexizyme 
In vitro translation of N-methyl peptides requires using N-methyl aminoacyl tRNAs in 
translation. In this chapter charging N-methyl amino acids on tRNAs is described and formation 
of N-methyl aminoacyl tRNAs is confirmed by MALDI/MS. The N-methyl aminoacyl tRNAs 
were used in translation which is discussed in chapter 3. 
2.1 Flexizyme 
Flexizyme is a ribozyme which catalyzes tRNA acylation. It has been developed by Suga and 
coworkers as an alternative method to make non-natural aminoacyl tRNAs
15
. Flexizyme can be 
used to charge any amino acid on any tRNA. It works by recognizing CCA sequence at the 3` 
end of tRNA as well as the aromatic side chain on amino acids. There are two types of 
Flexizyme: eFx and dFx. eFx can be used for amino acids with aromatic side chains that are 
activated by cyanomethyl ester group. However, dFx is used for amino acids without aromatic 
side chains and activated with dinitrobenzyl ester group.                                                              
2.2 N-methyl amino acids 
Six different N-methyl amino acids were chosen for the study: N-methyl alanine, N-methyl 
serine, N-methyl glycine, N-methyl phenylalanine, N-methyl p-nitro-phenylalanine and N-methyl 
tyrosine (Figure 3). These N-methyl amino acids have been reported to be incorporated well into 
peptides by Flexizyme combined with in vitro translation
2
. Among these amino acids, N-methyl 
phenylalanine, N-methyl p-nitro phenylalanine and N-methyl tyrosine have aromatic side chains 
and must be activated via the cyanomethyl ester derivative. For the other three amino acids 
6 
 
without aromatic side chains, the dinitrobenzyl ester group is needed for activation and 
recognition by Flexizyme. 
H
N
CH3
OH
O
HN
OH
O
OH
H
N
OH
O HN
OH
O
HO
H
N
OH
O
O2N
H
N
OH
O
a) b) c)
d) e) f)  
Figure 3. Structure of N-methyl amino acids a) N-methyl alanine, b) N-methyl serine, c) N-
methyl glycine, d) N-methyl phenylalanine, e) N-methyl tyrosine, f) N-methyl p-nitro-
phenylalanine 
2.3 Synthesis of DBE substrates 
In order to synthesize DBE substrates, Boc-protected N-methyl amino acids were used. The 
reaction occurs in presence of a base, triethylamine (TEA), which deprotonates the carboxylic 
acid group. The resulting nucleophile can attack 3,5-dinitrobenzyl chloride forming the ester 
bond. The reaction mixture was stirred in dimethylformamide at room temperature for 12 hours. 
2.3.1 Dinitrobenzyl ester substrate synthesis 
Formation of DBE substrates was confirmed by 
1
H NMR. 
7 
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N
O
OH
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NO2
O2N
1.DMF, TEA
2.HCl
NO2
NO2
O
O
H
N+
RT
HO
HO  
                                                                                  Yield: 65% 
Scheme 1. Synthesis of DBE substrate of alanine, glycine and serine 
 2.3.2 Cyanomethyl ester substrate synthesis 
Formation of CME substrates was confirmed by 
1
H NMR. 
N
OH
O
Cl
HN
O
O
N
+
1.MeCN, TEA
2.TFA/Anisole
9:1
Boc RT  
                                                                                                               Yield: 57% 
Scheme 2. Synthesis of CME substrate of phenylalanine 
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2.4 tRNA 
In order to facilitate synthesis of peptide libraries, tRNAs should be orthogonal and able to 
incorporate an N-methyl amino acid at a single template-directed position in a polypeptide 
without significant competition from other amino acids present in the translation mixture. 
tRNA
Asn-E2 
(NNN) is a tRNA which the Flexizyme system is able to efficiently charge unnatural 
amino acids onto (Figure 4)
17
.  
 
Figure 4. tRNA
Asn-E2
 (NNN) 
Six different tRNAs bearing unique anticodons (NNN) were chosen for this work (Table 1). 
These anticodons can replace amino acids for codons that can be read by only a single tRNA. 
This is important in order to assign a unique codon to each N-methyl amino acid in peptide 
library.  Codons ending in C or G were preferred because they make tighter interactions with 
complimentary bases (Figure 5). 
9 
 
 
Figure 5. Table of amino acid codons. Codons of amino acids in squares were chosen for library 
 
Table 1. tRNA/amino acid pairs 
tRNA
Asn-E2
 (NNN) Codon Natural amino acid Unnatural amino acid 
tRNA
 Asn-E2
 (GUC) GAC Aspartic acid N-Me-Alanine 
tRNA
Asn-E2
 (GUU) AAC Asparagine N-Me-Serine 
tRNA
Asn-E2
 (GUA) UAC Tyrosine N-Me-Tyrosine 
tRNA
Asn-E2
 (GAA) UUC Phenylalanine N-Me-Phenylalanine 
tRNA
Asn-E2
 (CUU) AAG Lysine N-Me-p-nitro phenylalanine 
tRNA
Asn-E2
 (GCU) AGC Cysteine N-Me-Glycine 
  
10 
 
2.4.1 Synthesis of tRNA 
These tRNAs were transcribed from their synthesized DNA sequences using T7 RNA 
polymerase. To prepare the templates, four different primers were synthesized, annealed together 
and amplified by PCR (figure 6). Table 2 shows the sequence of these four primers. Primer B 
and A were first amplified in PCR and then primer C which contains the T7 promoter sequence 
and D were added to be annealed to main template and make desired double strand DNA. Primer 
B is part of the tRNA, which has an anticodon sequence and therefore is different in each of the 
tRNAs. The DNA product was transcribed by using T7 polymerase and purified by 10% 
denaturing PAGE.  
Figure 6. Sequence of primers used in making DNA templates 
Table2. Sequence of DNA primers for each tRNA 
Primer A 
5’-GTAAT  ACGAC  TCACT  ATAGG CTCTG  TAGTT  CAGTC  GGTAG  AACGG 
CGGA-3’ 
  
 
Primer C 5’-GGCGT  AATAC  GACTC  ACTAT  AG-3’ 
 
11 
 
Primer D 5’-TGGCG  GCTCT  GACTG  GACTC GAACC  AGTGA  CATAC  GGA-3’  
 
tRNA
Asn-E2
 (NNN) Primer B 
tRNA
 Asn-E2
 (GUC) 5’-GAACC  AGTGA  CATAC  GGACT  GACAA  TCCGC  CGTTC  TACCG  ACT-3’ 
tRNA
Asn-E2
 (GUU) 5’-GAACC  AGTGA  CATAC  GGACT  AACAA  TCCGC  CGTTC  TACCG  ACT-3’ 
tRNA
Asn-E2
 (GUA) 5’-GAACC  AGTGA  CATAC  GGACT  TACAA  TCCGC  CGTTC  TACCG  ACT-3’ 
tRNA
Asn-E2
 (GAA) 5’-GAACC  AGTGA  CATAC  GGACT  TTCAA  TCCGC  CGTTC  TACCG  ACT-3’ 
tRNA
Asn-E2
 (CUU) 5’-GAACC  AGTGA  CATAC  GGACT  AAGAA  TCCGC  CGTTC  TACCG  ACT-3’ 
tRNA
Asn-E2
 (GCU) 5’-GAACC  AGTGA  CATAC  GGACT  TGCAA  TCCGC  CGTTC  TACCG  ACT-3’ 
                                            
2.4.2 PCR troubleshooting 
As described in section 2.4.1, DNAs sequencing desired tRNAs were made by PCR. To obtain 
the best PCR product main templates (A and B) were first amplified in two cycles by using Taq 
DNA enzyme. Then T7 Forward primer (Primer C) and primer D were added. After that PCR 
were run for 26 cycles and after 8
th
 cycle, time points were taken every other cycle. Data from 
time points showed us that 18 cycles is enough to get saturated PCR product. The concentration 
of primers was optimized. 
12 
 
 
Figure 7. PCR products of six DNA templates on 2% agarose gel; DNA: 1)GAC 2)AAC 3)UAC 
4)UUC 5)AAG 6)UGC 
 
 2.5 Flexizyme Reaction 
To measure the time needed for acylation of N-methyl amino acids by Flexizyme and to make 
sure that the correct aminoacyl-tRNA is made, we used a 
32
P and MALDI-TOF charging assay 
described in next sections.  
2.6 Labling tRNA with 
32
P 
A sensitive assay for aminoacylation of tRNA is the tRNA internucleotide labeling strategy 
described by Uhlenbeck and coworkers
18
.  The assay employs a 3`-
32
P-labled tRNA prepared by 
an exchange reaction with [!-
32
P] ATP and PPi catalyzed by E. coli tRNA terminal nucleotidyl 
transferase (scheme 3). The resulting tRNA has 
32
P at between the 3` terminal C and A. During 
the assay, the C-terminal A is aminoacylated.  Aliquots from the reaction are removed at various 
times and are quenched with nuclease P1 solution in acetate buffer at pH 5.0. This digestion 
13 
 
provides radiolabeled 
32
P-AMP and aminoacyl-AMP which reflects the amount of aminoacylated 
and nonacylated tRNA at certain time point. These two radioactive products were separated by 
PEI-TLC and their ratio measured by a phosphorimager. Figure 8 shows TLC analysis of the 
aminoacylation of N-methyl serine, N-methyl glycine and N-methyl alanine onto tRNA
Val
.  
 
Scheme 3. Labeling tRNA with 
32
P 
From this 
32
P assay data, the time point which gave the maximum yield was determined. The 
data for N-methyl amino acids is close to the literature report
19
 of aminoacylation of serine (4 
hr), glycine (2 hr), alanine (2 hr) acids with Flexizyme (Figure 9a, 9b and 9c).  
14 
 
 
Figure 8. TLC of 
32
P assay on N-methyl alanine, N-methyl serine and N-methyl glycine  
              
a)  
15 
 
b)  
c)  
Figure 9. Aminoacylation of N-methyl amino acids at different time points. (Y axis shows the 
fraction of Amp-AA and free Amp) 
 
 
16 
 
2.7 tRNA aminoacylation assay based on MALDI/MS  
An assay described by Szostak and coworkers
20
, based on MS was chosen to verify that the 
correct AA-tRNA product was formed. Using MS for direct detection of the large polyionic AA-
tRNA has low sensitivity, and it is unable to resolve the small mass differences between analogs.  
This assay solves these problems by cleaving the AA-tRNA into mononucleotides. To have 
higher mass in MALDI-MS, AA-tRNA was derivatized on the primary amine of the amino acid 
using reductive amination between the amine and aldehyde-containing triphenylphosphonium 
group. After derivatization the tRNA is digested with nuclease P1 at pH 5.0. MALDI-MS 
analysis of the derivatized AA-AMP identifies the amino acid that has been charged. In all mass 
spectra a peak corresponding derivatized AMP at mass 756.23 was observed.  
 
Figure 10. Derivatized AMP with phosphonium-containing benzaldehyde (2’ and 3’ of the 
tRNA, both can be acylated with the amino acid)  
 
17 
 
 
2.7.1 Aminoacylation of N-methyl amino acids on tRNA
 Asn-E2 
 
N-methyl alanine, N-methyl glycine, N-methyl serine and N-methyl phenylalanine were charged 
on tRNA
 Asn-E2
(GCU).The formation of aminoacyl-tRNAs were confirmed by MALDI/MS.  
Table 3. Mass of aminoacyl-tRNAs 
Aminoacyl tRNA Calculated Mass Observed Mass 
N-Me-Ser-Amp 858.212 857.343 
N-Me-Ala-Amp 841.332 842.338 
N-Me-Gly-Amp 827.431 828.31 
N-Me-Phe-Amp 917.311 918.115 
 
18 
 
 
Figure 11. MALDI/MS analysis of charged N-methyl alanine  
19 
 
 
Figure 12. MALDI/MS analysis of charged N-methyl glycine 
20 
 
 
 
Figure 13. MALDI/MS analysis of charged N-methyl serine 
21 
 
 
Figure 14. MALDI/MS analysis of charged N-methyl serine 
22 
 
2.8 Experimental section 
2.8.1 General methods 
All N-methyl amino acids were purchased from Chem Impex. Chloroacetonitrile was purchased 
from Sigma. All solvents (triethylamine, acetonitrile and dimethylformamide) were distilled 
prior to use in reaction.  
MALDI mass spectra were recorded using Micromass’ M@LDI (MALDI TOF) micro channel 
plate spectrometer. 1 "L of sample was mixed with 9 "L of MALDI matrix (1% w/v CHCA in 
1:1 MeCN: 0.1% trifluoroacetic acid) and 1 "L was spotted on MALDI plate. Mass scans were 
obtained in the range of 700-1200 m/z. 
1
HNMR was recorded on Bruker Avance 400 MHz spectrometer in DMSO-d6 All signals are 
reported in ppm with the residual DMSO peak assigned to 2.50. The data is reported as: chemical 
shifts (ppm), multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet) and integration. 
The DNA templates of tRNAs were made on MerMade 4 DNA synthesizer. Synthesized DNAs 
were deprotected with methylamine/ammonia mix solution and purified with 10% denaturing 
PAGE.  
32
P PEI TLC plates were analyzed using a Typhoon 9410 phosphoimager from GE Healthcare 
Company. 
2.8.2 Synthesis of N-methyl alanine dinitrobenzyl ester
2
 
N-Boc-methyl alanine (121.92 mg, 0.6 mmol) was dissolved in DMF (100 µL). Triethylamine 
(138 "L, 1 mmol) and 3’,5’-dinitrobenzyl chloride (108 mg, 0.5 mmol) were added and the 
23 
 
reaction was stirred at room temperature overnight. After the reaction was completed, liquid-
liquid extraction was done with diethyl ether (9 mL) and the solution was washed with of 0.5 M 
HCl (3 mL x 3), 4% NaHCO3 (3mL x 3) and brine (5mL). The ether layer was dried over MgSO4 
and concentrated under reduced pressure. The residue was dissolved in 2 mL of 1:3 
HCl:ethylacetate and incubated for 20 min at room temperature. The solution was concentrated 
under vacuum and the product was precipitated by the addition of diethylether (3 mL). The solid 
was filtered leaving 130 mg of a white powder (76%). 
1
H NMR (DMSO-d6, 400MHz) ! 9.35 (s, 
1H), 8.83 (s, 1H), 8.70 (s, 2H), 5.56 (s, 2H), 4.23 (q, 1H), 2.6 (s, 3H), 1.5 (d, 3H). 
2.8.3 Synthesis of N-methyl serine dinitrobenzyl ester 
N-Boc-methyl serine was prepared according to the procedure described for N-methyl alanine. 
The solid was filtered leaving white powder (64%). 
1
H NMR (DMSO-d6, 400MHz) ! 9.36 (d, 
1H), 8.86 (s, 2H), 8.75 (s, 1H), 5.54 (s, 2H), 4.31 (d, 2H) 3.97 (q, 1H), 2.6 (s, 3H), 1.5 (d, 3H).  
2.8.4 Synthesis of N-methyl glycine didnitrobenzyl ester 
N-Boc-methyl glycine was prepared according to the procedure described for N-methyl alanine. 
The solid was filtered leaving white powder (65%). 
1
H NMR (DMSO-d6, 400MHz) ! 9.36 (s, 
1H), 8.80 (s, 2H), 8.72 (s, 1H), 5.41 (s, 2H), 4.08 (q, 1H), 2.57 (s, 3H). 
2.8.5 Synthesis of N-methyl phenylalanine cyanomethyl ester
21
 
N-Boc-methyl phenylalanine (800 mg, 2.86 mmol) was dissolved in 2.85 mL acetonitrile. 2.85 
mL of triethylamine was added and the reaction mixture was cooled to 0 °C.  Chloroacetonitrile 
(361 "L, 5.72 mmol, 2 equiv) was added. The reaction was warmed to room temperature and 
24 
 
stirred overnight. Ethyl acetate (30 mL) was added to the solution and reaction mixture was 
extracted with 0.5 M HCl (30 mL). The organic layer was washed with brine (30 mL), dried over 
MgSO4 and concentrated under vacuum leaving yellow oil containing Boc-Phe-CME. 
Boc-Phe-CME was deprotected by 9:1 trifluoroacetic acid (TFA)/ anisole (500 "L) under argon 
for 30 min. The solvent was removed under vacuum and 4M HCl was added. The solvent was 
removed by vacuum and the product was precipitated by addition of anhydrous ether. The 
precipitate was dissolved in minimal amount of methanol and precipitated again by anhydrous 
ether leaving a powder (57%). 
1
H NMR (DMSO-d6, 400MHz) ! 7.24-7.34 (m, 5H), 5.10 (s, 2H), 
4.42 (t, 1H), 3.07-3.21 (m, 2H), 2.6 (s, 3H).  
2.8.6 Preparation of tRNA
Asn-E2
 (NNN) and flexizyme 
For the preparation of the DNA template for tRNA
Asn-E2
, primer A and B (0.5 "M each) were 
amplified with Taq DNA polymerase and then primer C and D were annealed to main template 
and extended. The resulted double strand DNA was transcribed in presence of T7 polymerase
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and purified by 10% denaturing PAGE. 
Following DNA templates were used in preparation of dFx and eFx
19
. They are then transcribed 
to Flexizyme in presence of T7 polymerase.  
dFx: 5’-TGGTACCTAACGCCATGTACCCTTTCGGGGATGCGGAAATCTTTCGATCC-3’ 
eFx: 5’-TGGTACCTAACGCTAATCCCCTTTCGGGGCCGCGGAAATCTTTCGATCC-3’     
T-7 Primer: 5'-TAA TAC GAC TCA CTA TAG GG-3' 
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2.8.7 Flexizyme reaction 
tRNA
Asn-E2
 (NNN) was first folded under the following conditions: 40 "M tRNA in 0.2 M 
HEPES-KOH buffer (pH 7.5) was heated in a PCR machine at 95 °C for 1 min followed by 
cooling to room temperature gradually over 5 min. 10 "L of 3M MgCl2 and 5 "L of 200"M dFx 
or eFx were added  to the solution. After 5 min, 10 "L of 25mM N-methylated amino acid 
substrate (DBE or CME) in DMSO was added to the mixture and incubated on ice for 1-4 hours. 
The acylation was quenched by addition of 150 "L 0.6 M NaOAc and the aminoacyl-tRNA was 
recovered after precipitation with 3 volumes of ethanol. 
 2.8.8 Labeling tRNA with 
32
P 
tRNAs 
32
P-labled at 3`-terminus were prepared by an ATP-PPi exchange reaction catalyzed by 
E. coli tRNA terminal nucleotidyl transferase. 20 mM Na Tris/MgCl2 pH 8.7, 1 "M tRNA, 0.17 
"M ["-
32
P] ATP (10 mCi/ml), 500 "M sodium pyrophosphate and tRNA nucleotidyltransferase 
(30 "g/ml) were added together and incubated in 37°C for 2 hours. The reaction was quenched 
with 10 "L inorganic pyrophosphatase (10 units/mL) and kept at 37°C for 2 min. The solution 
was extracted with phenol:CHCl3:isoamyl alcohol 25:24:1. The 32P-labled tRNA was passed 
through a NAP-5 column to be desalted and purified from unincorporated nucleotides. tRNA was 
recovered by YM-10 centrifugal filter units with membrane with 10000 molecular weight cut off 
and counted on a scintillation counter. 200000 cpm of this labeled-tRNA was used in the 
Flexizyme reaction, and the final conversion to aminoacyl tRNA was measured by determining 
the ratio between AA-AMP and AMP spots on a PEI-TLC plate. Samples were kept on ice for 
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aminoacylation. 1"L of sample was withdrawn at desired time points (0, 1, 2, 4, 18 and 24 
hours) and mixed with 4"L of 200mM NaOAc, pH 5.0 containing 1unit/"L nuclease P1.  The 
digest proceeded for 10 min at room temperature. Approximately 1"L of this sample was spotted 
on polyethylenimine-cellulose plates. The plates were pre-run with water and eluted with Glacial 
acetic acid and/ 1M NH4Cl/H2O (5:10:85). The intensity of the AA and AA-AMP spots were 
analyzed using a phorphorimager. 
2.8.9 tRNA aminoacylation assay based on MALDI/MS  
Aminoacyl tRNA prepared using the Flexizyme reaction was dissolved in 200 mM NaOAc (pH 
5.0, 12.5 "L). Half of the solution was stored at -20°C and the remaining half was added to water 
(3.75 "L) and freshly prepared 4-formylphenoxypropyl triphenyl phosphonium bromide (69 
mM, 12.5 "L) in MeOH. At the last step freshly prepared NaCNBH3 (200mM, 2.5 "L) dissolved 
in 50mM NaOAc, pH 5.0 was added and a white solid precipitated but then redissolved upon 
heating.  The solution was incubated in 37°C for 2 hours using a tumbler. The reaction was 
quenched by 4.4 M NH4OAc (pH 5.0, 2.5 "L) and the RNA was precipitated with 100% EtOH 
(75 "L). The solution was stored in -20°C for 20 min and centrifuged at high speed for 20 min at 
4°C. The pellet was washed with 70% EtOH (2X) and 100% EtOH (2x). The pellet was air dried 
for 5-10 min and then dissolved in 200 mM NH4OAc, pH 5.0 (2.25 "L) and 0.25 "L of 1 unit/"L 
nuclease P1 was added. After 20 min the reaction was quenched on ice and 1 "L of the solution 
was mixed with 9 "L of MALDI matrix (1% CHCA in 1:1 MeCN: 0.1% trifluoroacetic acid). 
The solution was vortexed and 1 "L was spotted on MALDI plate for analysis.  
2.9 Discussion 
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N-methyl amino acid substrates (CME or DBE) were synthesized. DNA templates for tRNAs 
were synthesized and amplified in PCR. PCR troubleshouting was done to obtain a single band 
from PCR products.  
The flexizyme system was used to charge N-methyl amino acids on tRNA
Asn-E1
 (NNN). The 
formation of aminoacyl-tRNA was confirmed using a MALDI-TOF charging assay and the 
percentage of charging was measured by using 
32
P labeled tRNA. The prepared aminoacyl-tRNA 
is ready for use in the PURE translation system to create N-methylated peptides (Chapter 3). 
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Chapter 3 
Translation 
In this chapter, incorporation of N-methyl amino acids into peptide was studied in vitro. N-
methyl amino acids were assigned for natural codons in PURE translation where N-methyl 
aminoacyl tRNAs were added. Formation of N-methylated peptides was confirmed with 
MALDI/MS. 
3. 1 PURE Translation 
PURE – protein synthesis using recombinant elements- is a reconstituted E. coli cell-free 
translation system
13
. The most important feature of this translation system is that some 
components, such as amino acids and aminoacyl-tRNA synthetases (aaRSs), can be withdrawn 
from translation mixture and therefore leave vacant specific codons. Later one can reassign the 
vacant codons to a desired unnatural amino acid to create unnatural peptides as programmed by a 
particular mRNA sequence.  
3.2 mRNA 
In this work an mRNA was designed to express a peptide with N-terminal His tag which was 
followed by eight different amino acids: Met-Phe-Asp-Asn-Tyr-Lys-Cys-Arg. In this sequence 
the desired N-methyl amino acids could be substituted instead of each of the natural ones. To 
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find an mRNA that could be transcribed and translated well, three different sequences of mRNA 
with same amino acid codons were designed and their efficiency in translation was compared to 
each other (Table 4). 
Table 4. Three mRNAs 
mRNA-1 
(Peptide) 
AUG CAC CAU CAC CAU CAC CAU AUG TTC GAC AAC TAC AAG TGC AGG UAG UAG 
MHHHHHHMFDNYKCR 
mRNA-2 
(Peptide) 
AUG CAC CAU CAC CAU CAC CAU AUG GAC TTC AAGAAC TGC TAC AGG UAG UAG  
MHHHHHHMDFKNCYR 
mRNA-3 
(Peptide) 
AUG CAC CAU CAC CAU CAC CAU AUG AAG AAC TGC TAC TTC GAC AGG UAG UAG  
MHHHHHHMKNCYFDR 
 
 
Figure 15. Translation yields of three mRNAs 
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mRNA-3 was chosen to be used in translations because it gave the highest yield.  
 
3.3 Incorporation of N-methyl amino acids in peptide 
PURE translation system was used for single incorporation of N-methyl glycine, N-methyl 
alanine and N-methyl phenylalanine into peptide backbones. N-methyl amino acids were charged 
on tRNAs by the Flexizyme system (chapter 2) and were used in PURE translation.  In choosing 
pairs of tRNA and amino acids, we tried to assign each natural amino acid codon to the same N-
methyl amino acid to maintain the side chain diversity in our peptide library. We selected a Phe 
codon (UUC) to assign to N-methyl phenylalanine charged on orthogonal tRNA
Asn-E2
. Cys codon 
(UGC) was selected for N-methyl glycine and Asn codon (AAC) was selected for N-methyl 
alanine. Figure 16 shows the yield of 50 µL translation for these three N-methyl amino acids. 
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Figure 16. In vitro translation of N-methyl alanine, N-methyl phenylalanine and N-methyl 
glycine 
 
Figure 17. MALDI/MS analysis of 50 "L translations with A) incorporated alanine B) 
incorporated glycine C) incorporated phenylalanine and D) positive control 
Yields were excellent for the 50 µL translation but desired mass peaks were not found on the 
MALDI/MS. Positive control which was a translation with natural amino acids had the peak 
corresponding to the correct as well as a 1260.48 peak. The 1260.48 peak corresponds to peptide 
consisting of Met-His-His-His-His-His-His-Met-Lys, which is part of the final peptide. This 
peak corresponds to translation termination before incorporation of Asn. For N-methyl alanine, 
N-methyl glycine and the positive control this 1260 peak was observed. In the case of N-methyl 
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phenylalanine, a peak at 1292 was detected, which most likely corresponds to the 
MHHHHHHMK peptide where the two methionine thioethers were oxidized. 
In these experiments, the concentration of aminoacyl-tRNA added to the translation was 10 µM. 
This concentration was much less than 100 µM, the value was reported in literature. However, 
for a 50 µL translation this would require significant amounts of transcribed tRNA
Asn-E2
. To 
solve the problem a smaller translation was designed. With 5 µl translation we could increase the 
concentration of aminoacyl-tRNA 10 fold. Therefore subsequent translations were done at a 5 
µL scale. 
Table 4 shows yields of single incorporation of three N-methyl amino acids in 5 µL translation. 
Except for the positive control no yield was obtained in the other assays. Also mass spectra from 
the three N-methyl amino acid assays did not show the expected masses.  
 
Figure 18. Translation yields for N-methyl amino acids (100 "M aminoacyl-tRNA)  
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Therefore the experiment was done with higher concentration (150 µM) of aminoacyl-tRNAs. 
Yields from this experiment are shown in figure 19. No peptides of the right mass were observed 
for the N-methyl amino acid experiments. This might be because of low yields of the peptides. A 
peptide of the correct mass was detected for the positive control, but it was much smaller than 
1260 truncation peak.  
 
Figure 19. Translation yields for N-methyl amino acids (150 "M aminoacyl-tRNA)  
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Figure 20. MALDI/MS analysis of incorporation of natural amino acids into the peptide 
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3.4 Short mRNA 
In all above translations a peak at mass 1260, which is corresponding to M(H)6MK, was 
observed (Figure 17 and 20). This might be because of inefficiency of the mRNA in complete 
translation. Therefore new mRNA was designed, which was shorter than previous one and 
encoded three amino acids. This mRNA should have less failure in its sequence and therefore 
more be more efficient. This short mRNA expresses a short peptide consisting of His tag peptide 
followed by Met-Phe-Asn-Cys. The efficiency of the mRNA was checked in a translation with 
natural amino acids and the yield of translated peptide was 3 pmol in 50 µL translation.  
The new short mRNA was used in a translation with a Cys codon assigned to N-methyl glycine. 
No yield was obtained for this translation while positive control worked well, showing no 
truncation.  
After these failures, we were concerned that our designer N-methyl AA/tRNA pairs were 
somehow incompatible with in vitro translation.  We therefore decided to use the exact N-methyl 
amino acid and tRNA pairs that were reported by Suga and coworkers
2
. To this end, N-methyl 
serine was charged on tRNA
Asn-E2 
(UUC). This pair was used in translation and the peptide with 
incorporated N-methyl serine was not detected while positive control gave a peptide of the 
correct mass. 
Therefore we thought perhaps the experimental technique was needed to be improved. In all    
previous translations the aminoacyl-tRNA pellet, which was precipitated in ethanol was air dried 
for 5 minutes prior to dissolving in water for translation. We reasoned that the pellet might not 
have dried completely and residual ethanol may reduce translation yields.  
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The translation of N-methyl serine was repeated and this time the aminoacyl tRNA was dried 
carefully over argon. The right mass of peptide with incorporated N-methyl-serine was detected 
by MALDI/MS. The yield of the translation was 1.49 pmol in 5 µL translation. 
 
Figure 21. Translation yield of N-methyl serine 
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Figure 22. MALDI/MS analysis of incorporation of N-methyl serine into the peptide 
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Figure 23. MALDI/MS analysis of incorporation of natural amino acids into the peptide 
39 
 
Using our new technique, N-methyl serine, N-methyl glycine and N-methyl phenylalanine were 
also tested in separate assays. Final peptide yields are shown in Figure 24. Peptide was produced 
in each assay, and MALDI confirmed the correct peptides were formed, except in the case of N-
methyl phenylalanine. The mass was matched to the peptide with misincorporation of histidine 
instead of Asp codon. That could be because of low concentration of aminoacyl-tRNA (25 µM) 
that was used. In Me-Phe and Me- Ser spectra masses at 1131.8 and 1131.7 were observed 
respectively which is corresponds to MHHHHHHM truncated peptide. In case of N-methyl 
glycine, a peak at 1393 was observed that corresponds to MHHHHHHMFN and shows that 
translation was not efficient in incorporation of part of N-methyl glycine and terminated before 
Cys codon. 
 
Figure 24. Translation yield of N-methyl serine, N-methyl glycine, N-methyl serine 
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 Figure 25. MALDI/MS analysis of incorporation of N-methyl glycine into the peptide 
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Figure 26. MALDI/MS analysis of incorporation of N-methyl phenylalanine into the peptide 
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Figure 27. MALDI/MS analysis of incorporation of N-methyl serine into the peptide 
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Figure 28. MALDI/MS analysis of incorporation of natural amino acids into the peptide 
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3.5 Experimental section 
3.5.1 General methods  
The DNA templates of mRNAs were synthesized on MerMade 4 DNA synthesizer.. Synthesized 
DNAs were deprotected with 1:1 solution of 40% methylamine and 30% ammonia mix solution 
and purified with 10% denaturing PAGE. 
MALDI mass spectra were recorded using Micromass’ M@LDI (MALDI TOF) micro channel 
plate spectrometer. 1 "L of sample was mixed with 9 "L of MALDI matrix (1% CHCA in 1:1 
MeCN: 0.1% trifluoroacetic acid) and 1 "L was spotted on MALDI plate. Mass scans were 
obtained in the range of 1100-1700 m/z for short mRNAs translations and 1100-2500 m/z for 
longer mRNA.  
Radioactivity of 
35
S-peptides was counted with Beckman coulter LS 6500, multi-purpose 
scintillation counter.  
3.5.2 PURE Translation 
For the synthesis of N-methylated peptides, the PURE translation system was used. Translation 
reaction were carried out in presence of 1 "M mRNA and 0.1mM of methylated aminoacyl-
tRNA and aminoacyl tRNA synthetase required for translation except the ones which were 
reassigned for N-methyl amino acids.  In each translation 200 "M of natural amino acids were 
used except methionine, which 10"M concentration was used. In case of the positive control, 
PURE translation was used with 200 "M of the natural amino acids and all aminoacyl tRNA 
synthetase required. 10 "Ci of 
35
S methionine was used besides 20 "M of methionine in order to 
radiolabel the peptide.  The translation mix was incubated for 3 hours in 37°C and quenched with 
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50 "L TBS (50 mM tris-HCl, [pH 8.0], 150 mM NaCl) buffer. The resulting peptide was 
captured on Ni-NTA resin by incubating for 1 hour at 25°C, washed with 500 "L TBS two times 
and was eluted with 50 "L 1% TFA solution. To measure the amount of translated peptide, 
peptides were labeled with 
35
S methionine.  40 "L of sample was diluted with scintillation fluid 
(2 mL) and counted with a scintillation counter. Specific activity of the peptides was in range of 
54183-173990 cpm/pmol. 
3.5.3 MALDI-TOF-MS Analysis 
The nonradiolable translated peptides were desalted with a C18 ziptip (Millipore) and eluted with 
50% acetonitrile, 0.1% TFA solution saturated with matrix (!-cyano-4-hydroxycinnamic acid). 1 
"L of sample was spotted on MALDI plate and detected with MALDI-TOF-MS. 
3.6 Discussion 
The goal of this part of the project was in vitro synthesis of N-methylated peptides. These 
experiments are complicated; however after optimization, the yields of the all-natural AA 
peptides reached 4.15 pmol in a 5 µL translation.  
To efficiently incorporate N-methyl amino acids into the peptide, different concentrations of 
aminoacyl tRNAs were used. However even at high concentrations of aminoacyl tRNAs, no 
peptides containing N-methyl amino acids were observed. Because the translation reactions with 
all natural AAs worked efficiently, we concluded that there might be something wrong in our 
preparations of the N-methyl aminoacyl-tRNAs we introduced into the translation system. 
Therefore the aminoacyl tRNAs were dried very carefully under argon and dissolved in fresh 
1mM NaOAc pH 5.0.  N-methylated peptides were obtained after this technical improvement. 
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Among the N- methyl amino acids that were used, N-methyl phenylalanine was not incorporated 
to the peptide efficiently. This might be because of the low concentration of the aminoacyl tRNA 
(25 "M) that was used.  
The next step is making a library of N-methylated peptides and for screening with a cell 
permeability assay. But to make a library of peptides, translation reactions of up to 5 ml are 
needed. In such a large-scale translation, a large amount of transcribed tRNA is also needed.. 
Therefore we decided to use tRNA from another source instead of transcription from DNA 
template. The next chapter focuses on purification of specific tRNAs from total tRNA. 
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Chapter 4 
Purification of individual tRNAs from total tRNA 
New study was done on purification of individual tRNAs from total tRNA. By tagging specific 
tRNAs with fluorous compound, they can be purified with fluorous-pak column. After 
deacylation, purified tRNA can be eluted from column and be used in translation. 
4.1 Purification of specific tRNAs from total tRNA 
As outlined in chapter 3, it is necessary for our experiments to obtain large amounts of individual 
tRNAs. Individual tRNAs can be made by in vitro transcription but lack of modifications of the 
tRNA transcripts may influence their function
23, 24
. Therefore developing a simple and rapid 
method for purification of specific tRNA from fully modified E. coli total tRNA would be 
advantageous.  
The purification of specific tRNAs from total tRNA is a process that requires multiple 
chromatographic steps
25
. People have tried to purify specific tRNAs by hydrophobic tagging by 
synthesizing Fmoc-aa-tRNA species. This technique has the advantages over previous 
methods
26
. For example, it is applicable for all tRNAs because it relies only on the selective 
aminoacylation it is cheap and the ester used in this study (FmocOSu) is stable and available at 
low cost. But this technique has been applied only to two types of tRNAs and separations require 
HPLC.  
4.1.1 Using fluorous affinity tag in purification of specific tRNAs 
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Fluorous–highly fluorinated-compounds have been used in different targeted synthesis, 
purification of small molecules, peptides and oligonucleotides
27
. Seperation of compounds base 
on fluorous tag is really reliable.  The utility of fluorous-based methodologies has been extended 
recently.  
We decided to try to extend fluorous tagging and purification to isolate individual tRNAs.  In 
order to this, desired tRNA will be charged with related amino acid. Using reductive amination 
reaction, the charged tRNA will be coupled with fluorous molecule. This tagged tRNA can stick 
to fluorous-pak column while others will pass through and be removed.  To release the tRNA 
from column, tRNA can be deacylated and then eluted with acetonitrile. 
4.2 Purification based on fluorous affinity 
The commercially available fluorous molecule 4-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-
Heptadecafluoroundecyloxy) benzaldehyde (1) (Figure 16) was chosen for this study. We 
reasoned that the aldehyde group could react via reductive amination to attach the fluorous tag to 
aminoacyl-tRNA, a reaction similar to our MALDI AARS assay. 
O
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Figure 29. Fluorous molecule (1) 
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4.2.1 Solubility 
The biggest problem with this fluorous compound is that it iis not water-soluble and therefore 
not compatible with our tRNA study. Many experiments were tried using organic co-solvents for  
the fluorous molecule but none were successful. Therefore we decided to sulfonate our fluorous 
molecule to make it more water-soluble.  
 
4.3 Sulfonation of compound (1) 
In order to sulfonate the fluorous molecule, first sulfuric acid was tried. The first reaction used 
30% sulfuric acid. But the fluorous molecule was not soluble.  The reaction was run for 24 hours 
and followed by TLC and NMR. No product formed.  
4.3.1 Solvent 
The solubility of the fluorous compound in various water miscible solvents was tested. The 
results are shown in table 5. However no solvents that were both able to dissolve the compound 
and unreactive to sulfuric acid were found.  
Table 5. Solubility of compound (1) in different solvents 
Solvent Dissolved the sample Miscible with water 
MeOH No Yes 
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DCM No No 
DMF Yes Yes 
Ethyl acetate No Yes 
Acetone Yes Yes 
DMSO Yes Yes 
 
4.3.2 Sulfuric acid percentage 
Therefore we have decided to do the reaction without any co-solvent but by increasing the 
concentration of sulfuric acid and therefore decreasing the water percentage. Experiments were 
designed in which different percentages of sulfuric acid were used. Table 6 shows the result of 
experiments with different concentrations of sulfuric acid. As expected the solubility was 
inversely proportional to the concentration of water. Reactions were followed by TLC and NMR. 
In all cases the molecule remained as starting material.  
 
Table 6. Different sulfuric acid percentages 
Sulfuric acid conc. Solubility of starting material Product 
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Sulfuric acid 20% Not soluble No 
Sulfuric acid 40% Partially soluble No 
Sulfuric acid 60% Partially soluble No 
Sulfuric acid 80% Partially soluble No 
Sulfuric acid 98% Soluble No 
 
4.3.3 Temperature 
After trying different sulfuric acid percentages, we decided to heat to push the reaction. Different 
temperatures were tried: 50°C, 75°C and 125°C. In case of 125°C color of reaction was changed. 
In all cases, reaction was followed by TLC, which did not show any progress in reaction. 
1
HNMR spectrum of the sample in 125°C showed a messy spectrum which did not match desired 
product. 
Finally we decided to use oleum, which is fuming sulfuric acid instead of normal sulfuric acid 
for this reaction. Oleum 25% was used and sample was completely soluble. The product was 
formed after 30 min. 
1
HNMR confirmed the formation of the product. The yield of the reaction 
was 72%. The final product did not need to be purified, and our delight was completely water-
soluble. 
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Scheme 4. Sulfonation of compound (1) 
4.4 Fluorous column 
Fluorous column was used in order to purify the individual tRNAs. Figure 30 shows the 
procedure followed in purification of fluorous-tagged tRNAs.  
 
Figure 30. Preparation of fluorous tagged tRNA and purification on column (F= Fluorous 
molecule) 
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4.5 Labeling tRNA with 
32
P 
To efficiently follow the aminoacyl-tRNA samples on column, we have decided to label the 
tRNA with 
32
P-ATP and follow the purification on column with radioactivity. The 
32
P labeling 
method was described in section 2.6. 
4.6 Loading cahrged tRNA on column 
Radio-labeled total tRNA was first charged with all natural amino acids and synthetases.  The 
tRNA was reacted with the sulfonated fluorous compound and then passed through the fluorous-
pak column. Two different techniques were tried for deacylation of the tRNA on column: tris 
buffer pH 8.8 and 0.01 M cupper solution. At the end sample was eluted with 20% ACN.Figure 
31 shows the experiment results. 
 
Figure 31. Purification of charged tRNA on fluorous column (Y axis shows the percentage of 
total input radioactivity) 
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The data shows that very little tRNA bound to the column. This might be because the amino acid 
charging assay did not work or failure in reductive amination reaction. Chraged tRNA was tested 
with 
32
P PEI TLC technique and result showed a failure in labeling tRNA with 
32
P. 
Therefore we repeated the 
32
P labeling tRNA with modifications such as increasing the total 
tRNA concentration and decreasing the ATP concentration. 
The labeled tRNA was charged with all 20 natural amino acids and tagged with the fluorous 
compound through a reductive amination reaction. The final compound was loaded onto the 
fluorous affinity column.  Figure 32 shows the result of this experiment. 
32
P counting showed 
that most of the sample passed through the column in the loading/washing steps. However 11% 
was eluted after treating with tris and elution with 20% ACN. But less than 2% was eluted with 
cupper. Because the column was still radioactive, we tried to expose the column to tris in longer 
time (1 hour) and elute it with 20% ACN.  
 
Figure 32. Purification of charged tRNA on fluorous column (Y axis shows the percentage of 
total input radioactivity) 
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Since we would expect that only tRNAs charged with amino acids would be fluorous tagged, we 
decided to determine the percentage of the total tRNAs that were AA-tRNAs in order to get an 
idea of the upper limit of what we could expect to be bound to the fluorous column. This was 
done using PEI-TLC method (Section 2.6). The phosphorimage showed that 52% of the tRNA 
was charged and 3% of whole radioactive sample was ATP. This modification applied to the 
calculation and showed us that approximately 23% of charged tRNA was eluted from column by 
treating column with ACN. 
 
 
Figure 33. PEI TLC of charged tRNA 
4.7 Experimental section 
4.7.1 General experimental methods 
4-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyloxy) benzaldehyde and oleum 
25% were purchased from sigma. Fluorous-pak columns were purchased from Berry and 
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Associates. Images of PEI TLC plates (Sigma) were taken from Typhoon 9410 phosphoimager 
from GE Healthcare Company. 
4.7.2 Synthesis of sodium 4-(4,4,5,5,6,6,7,7,8,8,10,10,11,11,11-heptadecafluoroundecyloxy 
sulfonate 
100 mg of aldehyde (1) was added to 160 "L of fuming sulfuric acid (oleum) and stirred for 30 
min in room temperature. The product was added to 3 mL of brine and the precipitate was 
filtered and dried under vacuum. 72 mg white solid was left (72%). 
1
H NMR (CDCl3, 400MHz) 
! 9.86 (s, 1H), 8.21 (d, 1H), 7.78 (s, 1H), 7.17 (d, 1H), 4.25 (t, 2H), 1.76 (m, 3H), 1.97 (m, 2H).  
4.7.3 Charging assay 
Amino acids were charged onto total tRNA by aminoacyl-tRNA synthetases. 200 "M of amino 
acids and 350 "M of total tRNA were used in presence of BSA (10 mg/ml) and 2-
mercaptoethanol (100 mM). HEPES buffer pH 7.4 (300 mM), 1M KCl and 1M MgCl2 were 
added and the reaction was allowed to proceed at 37°C for 30 min. The reaction was quenched 
with 3M NaOAc pH 5.2 (0.1 Vol) and aminoacyl tRNA was recovered from phenol: chloroform: 
isoamyl alcohol 23:24:1 extraction and ethanol precipitated. 
4.7.4 Reductive amination 
The pellet from charging assay was dissolved in 12.5 "L 200mM NaOAc pH 5.0 and half of that 
was used in reductive amination. 12.5 "L of 69 mM sulfonated fluorous tag was added with 2.5 
"L of 200mM NaCNBH3.The reaction was allowed to proceed at 37°C for 2 hours and was 
quenched with 0.1 volume of 4.4 "L of NH4OAc and 3 volume of 100% ethanol. The tRNA was 
allowed to precipitate and the resulting pellet was washed two times with EtOH 70% and two 
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times with EtOH 100%. The pellet was allowed to dry and then dissolved in 1 mL sodium 
acetate pH 5.2.  
4.7.5 Fluorous column 
Fluorous-pak column (Berry & associates) was preconditioned with first 2 mL ACN, then 2 mL 
0.1M TEAA, and finally 2 mL of water with loading rate of 2 seconds per drop. After that, 2 mL 
of sample diluted 1:1 with loading buffer (5% DMF, 10% NaCl in water) was loaded on the 
column with 5 seconds per drop loading rate
28
. The column was washed with 2 mL of 10% ACN 
in 0.1M of TEAA solution pH 7 and 2 mL of water. In the next step tris pH 8.8 (1 hr)
29
  or 
0.01M copper was used for deacylation and the column was washed again with 1 mL 0.1M 
TEAA and 1mL of water. Finally the sample was eluted with 20% ACN, 50% ACN or MeOH. A 
portion of the sample was analyzed using a scintillating counter. 
 4.8 Discussion 
A fluorous tag, which was sulfonated and therefore became water-soluble, was coupled with 
individual tRNA in total tRNA solution and purified with fluorous-pak column. The desired 
tRNA was deacylated on the column with tris buffer pH 8.8 and eluted with 20% ACN. 
Approximately 23% of the charged tRNA was recovered from the column. This initial result is 
promising and there are several parameters that could possibly be optimized.  For example, the 
time of reductive amination reaction or deacylation could be varied to maximize yields or 
recovery. 
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Conclusions 
Flexizyme system and PURE translation was used to synthesis N-methylated peptides. After 
optimization of translation peptides with incorporated N-methyl amino acids were obtained. 
However truncated peptides and misincorporation were observed in MALDI/MS spectra of 
translated peptides. Low concentrations of aminoacyl-tRNAs could be the reason of translation 
terminations. 
Using Flexizyme for preparation of aminoacyl tRNAs requires a significant amount of 
transcribed tRNA in order to make library of N-methylated peptides; therefore, anew project on 
purification of specific tRNAs from total tRNA was started. 
Desired E. coli tRNA was tagged with fluorous molecule and purified with fluorous-pak column. 
This tRNA can be charged with any amino acid by Flexizyme and be used in PURE translation.  
Libraries of N-methyl amino acids can be made and screened for peptides with suitable drug 
properties. 
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Appendix 
 
 
 
 
Figure 34. 
1
H NMR of dinitrobenzyl ester of N-methyl alanine 
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Figure 35. 
1
H NMR of dinitrobenzyl ester of N-methyl glycine 
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Figure 36. 
1
H NMR of dinitrobenzyl ester of N-methyl serine 
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Figure 37. 
1
H NMR of cyanomethyl ester of N-methyl phenyl alanine 
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Figure 38. 
1
H NMR of sulfoanted salt of 4-(4,4,5,5,6,6,7,7,8,8,10,10,11,11,11-
heptadecafluoroundecyloxy benzaldehyde 
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